Vanberra Signal

Honeywell Life Care

Curated by Signal

Cardiovascular monitoring systems, software and telehealth systems

Overview

Honeywell Life Care or Honeywell HomMed, is focused on developing monitoring solutions and telehealth systems. The company's LifeStream Manager was designed to improve patient care and management while streamlining clinical workflows; The LifeStream Analytics allows to deliver return on investment (ROI) information on the telehealth program; The LifeStream connect allows to integrate your Electronic health and medical records with most other point of care applications; The Lifestream View enables tracking for healthcare providers, families and patients. The company's LifeStream Clinical Software received FDA clearance in 2016 (K153719). The remote patient monitoring devices include Genesis DM (remote vital signs monitoring device), Genesis Touch remote patient monitoring device, peripherals and accessories.

Key facts

Founded
1991

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cancer treatment tracking app for patients

    Health TechnologyLos Angeles, United States
  • Provider of electronic health record management software for medical professionals

    Health TechnologyDenver, United States
  • Global health tourism platform that connects patients with the best doctors

    Health TechnologyNew York City, United States

About Honeywell Life Care

What does Honeywell Life Care do?

Honeywell Life Care or Honeywell HomMed, is focused on developing monitoring solutions and telehealth systems.

Where is Honeywell Life Care headquartered?

Honeywell Life Care is headquartered in Brookfield, United States.

When was Honeywell Life Care founded?

Honeywell Life Care was founded in 1991.

Which sector is Honeywell Life Care in?

Honeywell Life Care operates in Health Technology.

Who are Honeywell Life Care's competitors?

Companies similar to Honeywell Life Care include My Cancer Tracker, Clarity Care, and Avicennas.